Dermatology
Conference Coverage
Novel topical JAK inhibitor shows promise for atopic dermatitis
PARIS – Ruxolitinib may offer a desperately needed alternative to potent topical steroids.
From the Journals
Second-melanoma risk higher with indoor tanning
Tanning-bed users also had less time before the diagnosis of their second tumor.
From the Journals
AEDs strongly linked to rare serious skin reactions
The highest-risk AEDs were zonisamide, rufinamide, clorazepate, lamotrigine, carbamazepine, and phenytoin.
Conference Coverage
Tofacitinib impresses in first trial for dermatomyositis
CHICAGO – Evidence of strong clinical efficacy noted.
Quiz
A 77-year-old white male with a history of multiple nonmelanoma skin cancers as well as melanoma presented with an asymptomatic pink plaque on the vertex of the scalp.
A 77-year-old white male with a history of multiple nonmelanoma and melanoma skin cancers presented with an asymptomatic pink plaque on his scalp...
From the Journals
Atopic dermatitis hits mental health, quality of life
.
From the Journals
Caffeinated coffee intake linked to lower rosacea risk
Caffeinated coffee intake is linked to a decreased incidence of rosacea, results of a large, observational study suggest.
Conference Coverage
Ligelizumab outperformed omalizumab for refractory chronic spontaneous urticaria
PARIS – Investigational drug ligelizumab achieved a faster response, higher clearance rate in a phase 2b study.
Conference Coverage
Secukinumab shows promise in hidradenitis suppurativa
PARIS – Strong efficacy in a pilot study underscores the importance of the Th17 pathway in the pathogenesis of this disease.
Conference Coverage
Think barrier repair for acne patients
LAS VEGAS – Quality moisturization is a must for acne patients and has been shown to improve TEWL, normalize ceramides, and repair the microbiome...
Conference Coverage
AD update: New insight into pathogenesis, prevention, and treatments
LAS VEGAS – Filaggrin mutations appear to play a role in the development of AD, but not in a significant proportion of people with AD.